you are here:
Success
Alert
Please select a Day.
Info
388.80
3.35 (0.87%)

As on 14 May, 2021 | 03:59

Trade
Day Range
386.25
392.90
L H
52 Week Range
320.70
487.75
L H
Volume
3,423,148
*
i

* BSE Market Depth (14 May 2021)

BUY SELL
QTY PRICE PRICE QTY
65 389.05 389.30 2
88 388.35 389.90 88
200 388.30 389.95 1208
371 388.00 390.00 20
20 387.70 390.90 168
9570 Total Total 25568
Bid / Ask
388.95 / 388.95
388.95
3.55 (0.92%)

As on 14 May, 2021 | 04:00

Day Range
386.40
392.95
L H
52 Week Range
320.90
487.70
L H
Volume
149,500
*
i

* BSE Market Depth (14 May 2021)

BUY SELL
QTY PRICE PRICE QTY
65 389.05 389.30 2
88 388.35 389.90 88
200 388.30 389.95 1208
371 388.00 390.00 20
20 387.70 390.90 168
9570 Total Total 25568
Bid / Ask
388.95 / 388.95
--
-- (--%)

As on --

Day Range
--
--
L H
Open Interest Analysis
Long Unwinding

(OI , PRICE )

See Historical Trend

Volume
--
--
-- (--%)

As on --

Day Range
--
--
L H
Moneyness
--
Volume
--
NSE

#KnowBeforeYouInvest

Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Note :Financial Information is based on consolidated numbers.
Financials
    Ownerships
      Industry Comparison
        Others
          Open387.00
          Previous Close385.45
          UC Limit423.95
          LC Limit346.95
          Volume3,423,148.00
          VWAP389.84
          Mkt Cap (Rs. Cr.)46,679
          20D Avg Volume4,902,179
          20D Avg Delivery1,554,200
          Beta0.750.70
          Face Value5.00
          TTM EPS6.17
          TTM PE63.01
          Sector PE42.16
          Book Value Per Share70.90
          P/B5.48
          Dividend Yield0.00
          P/C32.05

          Advance Chart

          Click here to expand

          *Refresh in 20 seconds.

          MC Insights

          Strong Performer: Stock with good financial performance alongside good to expensive valuation, but lacks price momentum as suggested by technical indicators

          Price
          • Bearish Momentum - Below Short, Medium and Long Term Moving Averages
          • 21.23% away from 52 week low
          • 20.29% away from 52 week high
          • Underperformer - Biocon down by -4.46% v/s NIFTY 50 up by 1.19% in last 1 month
          • F&O data suggests Short Covering today
          Financials
          Piotroski Score
          i
          Piotroski F-Score determines the financial strength of the company and ranges between 0 to 9. Higher the score, better the financials of the company.
          5

          indicates Average Financials

          3 year CAGR growth
          Revenue 19.3%
          NetProfit 25.7%
          OperatingProfit 25.9%
          Industry Comparison
          • TTM PE Ratio - Market Runner Up
          • Market Cap - Market Leader
          • Price to Book Ratio - Above industry Median
          • TTM PEG Ratio - Negative PEG TTM PE to Growth
          Shareholding Pattern
          • Promoters holding remains unchanged at 60.67% in Mar 2021 qtr
          • Mutual Funds have decreased holdings from 3.05% to 2.51% in Mar 2021 qtr
          • Number of MF schemes decreased from 26 to 21 in Mar 2021 qtr
          • FII/FPI have decreased holdings from 17.65% to 16.3% in Mar 2021 qtr
          • Number of FII/FPI investors decreased from 508 to 473 in Mar 2021 qtr
          • Institutional Investors have decreased holdings from 23.68% to 23.43% in Mar 2021 qtr

          MC Technicals

          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

            R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

          Moving Averages
          Days
          5 - -
          10 - -
          20 - -
          50 - -
          100 - -
          200 - -
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

          Moving Averages
          Days
          TECHNICAL RATING
          i
          This represents current trend.
          Click here for disclaimer.
          Moving Averages Bearish
          Technical Indicators Bearish
          Moving Averages Crossovers Bearish

          Pivot levels

          Type R1 R2 R3 PP S1 S2 S3
          Classic - - - - - - - - - - - - - -
          Fibonacci - - - - - - - - - - - - - -
          Camarilla - - - - - - - - - - - - - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Pivot levels

          R1 - - Pivot
          - -
          S1 - -
          R2 - - S2 - -
          R3 - - S3 - -

          Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

          Moving Averages
          Days

          Price and Volume

          Price Performance
          1 Week
          --%
          1 Month
          --%
          3 Months
          --%
          YTD
          --%
          1 Year
          --%
          3 Years
          --%
          Volume Analysis

          Forum

          Community Sentiments

          • 100% BUY
          • 0% SELL
          • 0% HOLD
          100%
          of moneycontrol users recommend buying Biocon

          What's your call on Biocon today?

          Read 21 investor views

          BUY SELL HOLD

          Broker Research

          22 Jan, 2021

          Sharekhan

          Reco Price 393.80 Target Price 470
          22 Jan, 2021

          Motilal Oswal

          Reco Price 393.80 Target Price 385
          22 Jan, 2021

          ICICIdirect.com

          Reco Price 393.80 Target Price 450
          28 Dec, 2020

          Sharekhan

          Reco Price 465.80 Target Price 520

          Deals

          05 Aug, 2020

          BOFA SECURITIES EUROPE SA

          Qty 272822 Price 413.8 % Traded 0.02
          05 Aug, 2020

          MERRILL LYNCH MARKETS SINGAPORE PTE LTD

          Qty 272822 Price 413.8 % Traded 0.02
          11 Jan, 2018

          OKOWORLD GROWING MARKETS 2.0

          Qty 200000 Price 542 % Traded 0.02
          11 Jan, 2018

          HAUCK & AUFHAUSER PRIVATBANKIERS KGAA NIEDERLASSUNG LUXEMB

          Qty 200000 Price 542 % Traded 0.02
          29 Mar, 2017

          MK FAMILY PRIVATE TRUST

          Qty 1000000 Price 1150 % Traded 0.08
          29 Mar, 2017

          SMK FAMILY PRIVATE TRUST

          Qty 1000000 Price 1150 % Traded 0.08
          29 Mar, 2017

          MURALI KRISHNAN KARAIKAL NARAYANASWAMY

          Qty 2000000 Price 1150 % Traded 0.17
          23 Feb, 2016

          NEW INDIA INVESTMENT TRUST PLC

          Qty 240000 Price 471.35 % Traded 0.02

          *Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

          29 May, 2020

          BLACKROCK ADVISORS LLC A/C THE MASTER TRUST BANK OF JAPAN L

          Qty 11749167 Price 354.76 % Traded 0.98
          29 May, 2020

          INTEGRATED CORE STRATEGIES (ASIA) PTE. LTD.

          Qty 6528193 Price 354.22 % Traded 0.54
          29 Mar, 2017

          MK FAMILY PRIVATE TRUST

          Qty 1000000 Price 1150 % Traded 0.08
          29 Mar, 2017

          SMK FAMILY PRIVATE TRUST

          Qty 1000000 Price 1150 % Traded 0.08
          29 Mar, 2017

          MURALI KRISHNAN KARAIKAL NARAYANASWAMY

          Qty 2000000 Price 1150 % Traded 0.17

          *A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

          Insider Transaction Summary

          Apr, 21, 2021

          PRASAD B S V

          Designated Person
          Qty 33750 Price 409.6 % Traded 0.00 Post Tnx Hold. 0%
          Apr, 21, 2021

          NEHAL VORA

          Designated Person
          Qty 45000 Price 409.6 % Traded 0.00 Post Tnx Hold. 0%
          Apr, 05, 2021

          SETHUMADHAVAN SANKARAN

          Designated Person
          Qty 7000 Price 402.86 % Traded 0.00 Post Tnx Hold. 0%
          Apr, 01, 2021

          KAMESWARARAO A V

          Other
          Qty 10000 Price 397.4 % Traded 0.00 Post Tnx Hold. 0%
          Mar, 31, 2021

          KRISHNASAI TANNEERU

          Designated Person
          Qty 13000 Price 400.46 % Traded 0.00 Post Tnx Hold. 0%
          Mar, 26, 2021

          AMITAVA SAHA

          Designated Person
          Qty 2900 Price 398.77 % Traded 0.00 Post Tnx Hold. 0%

          *Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015

          No Data For Substantial Acquisition of Shares & Takeovers.

          *Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

          Financials

          • Revenue
          • Net Profit
          • EPS
          • Revenue
          • Net Profit
          • EPS

          Shareholding

          PEERS

          Company Name Price % Chg MCap(Cr) TTM PE P/B ROE 1 Yr Perform Net Profit Net Sales Debt to Equity
          Biocon 388.80 0.87 46679.33 63.01 5.49 9.70 16.01 925 7,105 0.47
          Sun Pharma Adv 222.20 -7.51 5822.70 - - 0.00 66.50 -312 76 -3.64
          Vivo Biotech 64.25 -1.23 89.08 18.15 2.38 13.44 133.21 4 55 0.74
          ANG Lifescience 156.60 15.15 81.17 - 2.35 17.64 281.95 6 126 0.53
          Piramal Phytoca 22.55 0.00 58.54 - - 0.00 - -8 25 -0.53

          About the Company

          Biocon Ltd manufactures biotechnological products catering to the healthcare segment. The company is engaged in all phases of the product cycle from discovering to development & then commercializing the same drugs. They use fermentation-based technology, creating cost effective drugs.Biocon produces anti diabetic agents like Acarbose, Pioglitazone, Repaglinides & Rosiglitazone. In the biological segment they produce Insulin, Erythropoietin (EPO), Filgrastim (GCSF), Streptokinase & Monoclonal Antibodies. The company also produces & markets a mix of specialty & industrial enzymes for industries like paper, brewing, beverages, food, brewing, textiles & distilling. The companys drug portfolio consists of lovastatin, simvastatin, pravastatin and atorvastatin.
          {"success":1,"data":{"address":{"address1":"20th K.M. Hosur Road,\n","address2":"Electronics City,\n,","city":"Bengaluru","state":"Karnataka","pincode":"560100","telephone1":"080-28082808","telephone2":"","fax1":"080-28523423","fax2":"","email":"investor.relations@biocon.com","web":"http:\/\/www.biocon.com"},"management":[{"name":"Kiran Mazumdar Shaw","designation":"Executive Chairperson"},{"name":"John Shaw","designation":"Vice Chairman & Non Exe.Dire"},{"name":"Siddharth Mittal","designation":"Managing Director & CEO"},{"name":"Ravi Mazumdar","designation":"Non Executive Director"},{"name":"Mary Harney","designation":"Independent Director"}],"registrars":{"name":"KFIN Technologies Pvt. Ltd.","address1":"Selenium Tower B, Plot No. 31-32,","address2":"Gachibowli, Financial District, \nNanakramguda,Seri","address3":"","address4":"","telephone":"040-67161500, 67162222, 33211000","fax":"040-23420814, 23001153","email":"einward.ris@karvy.com","internet":"http:\/\/www.kfintech.com","city":"Hyderabad","state":"Telangana","pincode":"500032"},"listing":[{"name":"BSE 100","value":"Yes"},{"name":"BSE 200","value":"Yes"},{"name":"SENSEX","value":"No"},{"name":"CNX MIDCAP 200","value":"No"},{"name":"NIFTY 50","value":"No"},{"name":"BSE 500","value":"Yes"}],"details":{"bseId":"532523","nseId":"BIOCON","series":"EQ","isinid":"INE376G01013"}}}
          • Registered Office

          • Registrars

            • Address

              Selenium Tower B, Plot No. 31-32,,Gachibowli, Financial District, Nanakramguda,Seri

            • City

              Hyderabad 500032

            • State

              Telangana

            • Tel. No.

              040-67161500, 67162222, 33211000

            • Fax No.

              040-23420814, 23001153

            • Email

              einward.ris@karvy.com

            • Internet

              http://www.kfintech.com

          • Management

            • Kiran Mazumdar Shaw

              Executive Chairperson

            • John Shaw

              Vice Chairman & Non Exe.Dire

            • Siddharth Mittal

              Managing Director & CEO

            • Ravi Mazumdar

              Non Executive Director

            • Mary Harney

              Independent Director

          • Included In

            • BSE 100

              Yes

            • BSE 200

              Yes

            • SENSEX

              No

            • CNX MIDCAP 200

              No

            • NIFTY 50

              No

            • BSE 500

              Yes

          • Details

            • BSE:

              532523

            • NSE:

              BIOCON

            • Series

              EQ

            • ISIN

              INE376G01013

          Your feedback matters! Tell us what we got right and what we didn’t? Click here>